Regulation - Santhera Pharmaceuticals


Current filters:

Santhera Pharmaceuticals

Popular Filters

Santhera's Raxone granted temporary use in France


Switzerland-based Santhera Pharmaceuticals (SIX: SANN) announced today that the French National Agency…

FranceNeurologicalPharmaceuticalRaxoneRegulationSanthera Pharmaceuticals

Good EMA news for Pfizer's Bosulif but not for Santhera's Raxone


Following its monthly meetings last week, the European Medicines Agency the Committee for Medicinal Products…

BiotechnologyBosulifEuropeOncologyOphthalmicsPfizerPharmaceuticalRaxoneRegulationSanthera Pharmaceuticals

Back to top